BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 396842)

  • 1. [The anti-edematous effect of an association of proteolytic enzymes, flavonoids, sterolic heteroside of Ruscus aculeatus and ascorbic acid (author's transl)].
    Tarayre JP; Lauressergues H
    Ann Pharm Fr; 1979; 37(5-6):191-8. PubMed ID: 396842
    [No Abstract]   [Full Text] [Related]  

  • 2. Advantages of a combination of proteolytic enzymes, flavonoids and ascorbic acid in comparison with non-steroid anti-inflammatory agents.
    Tarayre JP; Lauressergues H
    Arzneimittelforschung; 1977; 27(6):1144-9. PubMed ID: 578429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study of the efficacy of Cirkan in phlebology].
    Elbaz C
    Phlebologie; 1980; 33(2):379-90. PubMed ID: 7005912
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cirkan-induced chronic diarrhea].
    Maechel H
    Gastroenterol Clin Biol; 1992; 16(4):373. PubMed ID: 1397865
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-inflammatory properties of asperase--a new enzymatic substance with proteolytic action].
    Maslov NF; Liubetskaia ZhA
    Farmakol Toksikol; 1987; 50(3):100-2. PubMed ID: 3301396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-inflammatory proteolytic enzymes in obstetrics and gynecology].
    Godts P
    Brux Med; 1971 Apr; 51(4):281-6. PubMed ID: 5578824
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical effects of proteolytic enzymes after reconstructive hand surgery. A double-blind evaluation of oral trypsin-chymotrypsin.
    McCue FC; Webster TM; Gieck J
    Int Surg; 1972 Jun; 57(6):479-82. PubMed ID: 4556847
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-inflammatory action of a protease, TSP, produced by Serratia].
    Yamasaki H; Tsuji H; Saeki K
    Nihon Yakurigaku Zasshi; 1967 Jul; 63(4):302-14. PubMed ID: 4228899
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes on venous diameter and leg perimeter with different clinical treatments for moderate chronic venous disease: evaluation using Duplex scanning and perimeter measurements.
    Porto CL; Milhomens AL; Pires CE; Xavier SS; Sicuro F; Bottino DA; Bouskela E
    Int Angiol; 2009 Jun; 28(3):222-31. PubMed ID: 19506542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of proteolytic enzymes for the prevention of sequelae of ionizing radiation in animals irradiated in the prenatal period].
    Uspenskiĭ IuN; Gendzelevskaia ZN; Goriacheva IA
    Radiobiologiia; 1974; 14(5):770-3. PubMed ID: 4431933
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of proteolytic enzymes (trypsin, chymotrypsin, streptokinase, streptodornase, papain) in stomatology].
    Protasevich AI
    Stomatologiia (Mosk); 1967; 46(5):107-9. PubMed ID: 4863251
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of varices of the lower extremities with a new drug combination: hemotrypsin].
    Grosso F; Vetrò A
    Atti Accad Med Lomb; 1975; 30(1-3):161-4. PubMed ID: 1234845
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacodynamic research on the antianemia effect of rutozid combinations with iron and ascorbic acid].
    Cristea E; Mihele D; Oiţă N
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(3):471-3. PubMed ID: 3832283
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of proteolytic enzymes in the treatment of inflammatory diseases of the soft tissues].
    Chudakov MI; Shkliarov SKh
    Khirurgiia (Mosk); 1972 Feb; 49(2):87-91. PubMed ID: 4658218
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytolytic hepatitis with a venotonic drug.
    Sgro C; Taque R; Zoll A; Hillon P
    J Hepatol; 1995 Feb; 22(2):251. PubMed ID: 7790717
    [No Abstract]   [Full Text] [Related]  

  • 16. [Proteolytic enzymes in treating acute thrombophlebitis of hemorrhoidal nodes].
    Geller AN
    Khirurgiia (Mosk); 1972 Feb; 49(2):64-5. PubMed ID: 4572242
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and capillaroscopic evaluation in the treatment of chronic venous insufficiency with Ruscus aculeatus, hesperidin methylchalcone and ascorbic acid in venous insufficiency treatment of ambulatory patients.
    Aguilar Peralta GR; Arévalo Gardoqui J; Llamas Macías FJ; Navarro Ceja VH; Mendoza Cisneros SA; Martínez Macías CG
    Int Angiol; 2007 Dec; 26(4):378-84. PubMed ID: 18091707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of sciatica with proteolytic enzyme].
    Gaspardy G
    Rev Rhum Mal Osteoartic; 1971; 38(6):476-8. PubMed ID: 5119615
    [No Abstract]   [Full Text] [Related]  

  • 19. Quality of life improvement in Latin American patients suffering from chronic venous disorder using a combination of Ruscus aculeatus and hesperidin methyl-chalcone and ascorbic acid (quality study).
    Guex JJ; Avril L; Enrici E; Enriquez E; Lis C; Taïeb C
    Int Angiol; 2010 Dec; 29(6):525-32. PubMed ID: 21173734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemorrhoids: a new drug therapy].
    D'Arrigo C
    Minerva Med; 1969 Oct; 60(87):4327-34. PubMed ID: 5354513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.